Androgen Effects Mediated by AR and Proto-Oncoproteins

Shemshedini, Lirim

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 1R29DK051274-01
• Application #: 2152374
• Study Section: Biochemical Endocrinology Study Section (BCE)
• Project Start: 1996-08-01
• Project End: 2001-07-31
• Budget Start: 1996-08-01
• Budget End: 1997-07-31
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: University of Toledo
• Department: Biology
• Type: Schools of Arts and Sciences
• City: Toledo
• State: OH
• Country: United States
• Zip Code: 43606

Publications

Zheng, Zhe; Cai, Changmeng; Omwancha, Josephat et al. (2006) SUMO-3 enhances androgen receptor transcriptional activity through a sumoylation-independent mechanism in prostate cancer cells. J Biol Chem 281:4002-12

Shen, X Q; Bubulya, A; Zhou, X F et al. (1999) Ligand-free RAR can interact with the RNA polymerase II subunit hsRPB7 and repress transcription. Endocrine 10:281-9

Zhou, X F; Shen, X Q; Shemshedini, L (1999) Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization. Mol Endocrinol 13:276-85